Man

Margarita Kam-lem Lay Remolcoi

PROFESOR ASISTENTE

UNIVERSIDAD DE ANTOFAGASTA

ANTOFAGASTA, Chile

Líneas de Investigación


Estudio de mecanismos moleculares de la respuesta inmune y la patogénesis después de infecciones con el Virus Respiratorio Sincicial, el Metapneumovirus humano y los Norovirus humanos; desarrollo de vacunas y productos biotecnológicos biomédicos.

Educación

  •  BIOLOGICAL SCIENCES , PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1994
  •  BIOLOGY, WASHINGTON UNIVERSITY IN ST. LOUIS. Estados Unidos, 2002
  •  MOLECULAR VIROLOGY AND MICROBIOLOGY, BAYLOR COLLEGE OF MEDICINE. Estados Unidos, 2011

Experiencia Académica

  •   PROFESIONAL DE LABORATORIO Full Time

    UNIVERSIDAD DE CHILE

    MEDICINA

    SANTIAGO, Chile

    1995 - 1996

  •   RESERACH ASSISTANT Full Time

    WASHINGTON UNIVERSITY IN ST. LOUIS

    BIOLOGICAL SCIENCES

    ST LOUIS, Estados Unidos

    1997 - 2000

  •   RESEARCH ASSISTANT Full Time

    WASHINGTON UNIVERSITY IN ST. LOUIS

    MEDICINE

    ST LOUIS, Estados Unidos

    2000 - 2003

  •   POSTDOCTORADO Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    CIENCIAS BIOLÓGICAS

    SANTIAGO, Chile

    2011 - 2015

  •   PROFESOR ASISTENTE Full Time

    UNIVERSIDAD DE ANTOFAGASTA

    CIENCIAS DEL MAR Y RECURSOS BIOLÓGICOS

    ANTOFAGASTA, Chile

    2016 - At present

Experiencia Profesional

  •   PROFESOR ASISTENTE Full Time

    UNIVERSIDAD DE ANTOFAGASTA

    ANTOFAGASTA, Chile

    2016 - At present

Formación de Capital Humano


Thesis Students:
Undergraduate:
- Macarena Juárez, Medical Technology, Universidad de Antofagasta
- Bayron Bruna, Medical Technology, Universidad de Antofagasta
- Aura Jiménez, Medical Technology, Universidad de Antofagasta
- Marisela Ledezma, Medical Technology, Universidad de Antofagasta
- Brian Parra, Biotechnology, Universidad de Antofagasta.
Postgraduate:
- Andrea Avellanada, Program Master of Biomedical Sciences, Universidad de Antofagasta


Difusión y Transferencia


Participation in Invited Seminars and Meetings
1. June 24-25, 2013: Institute Millennium of Immunology and Immunotherapy Annual
Meeting. Santiago, Chile.
2. November 21, 2013: Spring Symposium of Immunology, Pontificia Universidad
Católica de Chile. Santiago, Chile.
3. August 1, 2014: II Cycle of Seminars of the Center of Genomic and Bioinformatics
at the Universidad Mayor, Campus Huechuraba, Santiago, Chile.
4. August 20, 2014: Institute Millennium of Immunology and Immunotherapy Annual
Meeting. Santiago, Chile.
5. June 1-2, 2015: RSV Vaccine Workshop, National Institutes of Health, Bethesda,
Maryland, USA.
6. April 20, 2016: Seminar at the Department of Molecular Virology and Microbiology,
Baylor College of Medicine, Houston, Texas, USA.
7. October 09-13, 2016: 6th International Calicivirus Conference, Savannah, Georgia,
USA.
8. May 15?17, 2017: Workshop “FOCIS Goes South: Advances in Translacional and
Clinical Immunology”, Pontificia Universidad Católica de Chile. Santiago, Chile.
9. August 1-5, 2017: XXXIV National Congress of students of biochemistry and
related careers of 2017, Universidad de Antofagasta, Antofagasta, Chile.
10. November 14-17, 2017: XXXIX Chilean Congress of Microbiology, La Serena,
Chile.
11. December 1, 2017: II Simposio de Tendencias en Ciencias Farmacéuticas: "Cómo
convivir con virus y bacteria, los desafíos del siglo XXI, Universidad Católica del Norte, Antofagasta


Premios y Distinciones

  •   MARGARITA LAY

    BILL AND MELINDA GATES FOUNDATION

    Estados Unidos, 2015

    Young Investigator award recipient of IMMUNOCOLOMBIA 2015, 11th Congress of the Latin American Association of the Bill and Melinda Gates Foundation in Immunology (ALAI) and 10th Colombian Congress of Allergy, Asthma and Immunology (ACCAI). Medellin, October 13-16, 2015

  •   MARGARITA LAY

    American Society for Virology

    Estados Unidos, 2009

    Student travel award recipient of the AAI to attend the American Society for Virology 28th annual meeting at the University of British Columbia, Vancouver, BC, Canada, July 11-15th. 2009


 

Article (14)

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and Human Metapneumovirus infection.
New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.
Replication of human norovirus RNA in mammalian cells reveals a lack of interferon response
Elevated IL-3 and IL-12p40 levels in the lower airway of infants with RSV-induced bronchiolitis correlate with recurrent wheezing.
Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice.
Inflammatory damage on respiratory and nervous systems due to hRSV infection.
Understanding Lung Immunopathology Caused by the Human Metapneumovirus: Implications for Rational Vaccine Design.
Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells.
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans.
Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes.
STAT1-dependent innate immunity to a Norwalk-like virus.
Heme Oxygenase-1 modulates Human Respiratory Syncytial Virus replication and lung pathogenesis during infection

Abstract (1)

Human metapneumovirus infection induces expression of thymic stromal lymphopoetin and IL-33 in airway epithelial cells in vitro and lung infiltration of OX40L+DCs in vivo

Patent (2)

Use of antibodies or neutralizing molecules against TSLP, OX40L and CD177, as a treatment to ameliorate the disease in patients infected with human Metapneumovirus
Use of Molecular Biomarkers of IL-3, IL-33, IL-12p40 and TSLP to characterize the severity of respiratory infections for Respiratory Syncytial Virus and human Metapneumovirus

Proyecto (4)

CREACIÓN DEL ATACAMA DESERT VACCINE LABORATORY PARA DESARROLLAR VACUNAS EN ANTOFAGASTA
Design of a Center for Manufacturing of Vaccines and Antibodies for Diagnostic and Therapy in the Metropolitan Region of Chile
Vaccine against Respiratory Syncytial Virus
Estudio De La Respuesta Inmune Moduladas Por Celulas Epiteliales Humanas Hacia El Virus Respiratorio Sincicial Y El Metapneumovirus Humano 

Review (1)

Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution
9
Margarita Lay

PROFESOR ASISTENTE

BIOTECNOLOGÍA

UNIVERSIDAD DE ANTOFAGASTA

ANTOFAGASTA, Chile

2
Claudia Riedel

Full Professor

Life Sciences

Universidad Andres Bello

Santiago, Chile

1
Leandro Carreño

Profesor Asistente

Instituto de Ciencias Biomédicas

Universidad de Chile

Santiago, Chile

1
Gisela Canedo

Investigadora y Profesora

Facultad de Odontología

Universidad de Los Andes

Santiago, Chile

1
Orlando Acevedo

Tesista de Doctorado

Genetica Molecular y Microbiología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Emma Rey

Professor/Researcher

Instituto de Ciencias e Innovación en Medicina (ICIM)

Universidad del Desarrollo

Santiago, Chile

1
Alexis Kalergis

Full Professor

Microbiología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE. FACULTAD DE CIENCIAS BIOLÓGICAS

Santiago, Chile

1
Susan Bueno

Profesor Asociado

Genética Molecular y Microbiología

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Christian Palavecino

Profesor asistente

Universidad Central de Chile

Santiago, Chile

1
Felipe Tapia

Director de Proyectos

Ingeniería de Bioprocesos

Profesional Independiente

Puerto Montt, Chile